<DOC>
	<DOCNO>NCT02324309</DOCNO>
	<brief_summary>The study design compare meal time glucose control associate BIOD-531 , rapidly absorb concentrated insulin associate Humalog Mix 75/25 Humulin R U-500 patient diabetes severe insulin resistance .</brief_summary>
	<brief_title>BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control Patients With Severe Insulin Resistance</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<criteria>BMI &gt; 25 kg/m2 Diabetes Mellitus use ≥ 150 unit insulin insulin analog per day and/or ≥ 100 unit insulin insulin analog single dose session least 1 month prior screen HbA1c &lt; 10.0 % History bariatric surgery Corticosteroid therapy Significant cardiovascular major organ disease Females breast feeding pregnant A sexually active person use adequate contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>